Skip to content
Use caution Drug recall · FDA · Published September 26, 2014

Actavis Recalls Diclofenac/Misoprostol Tablets Due to Broken Tablets

Actavis recalls 5,451 bottles of Diclofenac Sodium and Misoprostol tablets due to split or broken tablets. Check lot #694320A.

🇺🇸 FDA recall #D-0258-2015DrugActavis ›
Take action

Contact the company

Recalling firmActavis Laboratories, FL, Inc.4955 Orange Dr · Davie, FL 33314-3902
✎ GovInfoNow plain-language explainer

Actavis Laboratories is recalling one lot of Diclofenac Sodium and Misoprostol Delayed-Release Tablets because some tablets may be split or broken. The recall affects 5,451 bottles distributed nationwide. The record does not specify the remedy for consumers. Read more at govinfonow.com/recall/45749-actavis-laboratories-fl-inc-recalls-diclofenac-sodium-and-misoprostol-delayed.

Source Summary by GovInfoNow · govinfonow.com/recall/45749-actavis-laboratories-fl-inc-recalls-diclofenac-sodium-and-misoprostol-delayed · Updated October 12, 2026 · FDA enforcement record: FDA #D-0258-2015

Cite this page

“Actavis Recalls Diclofenac/Misoprostol Tablets Due to Broken Tablets.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/45749-actavis-laboratories-fl-inc-recalls-diclofenac-sodium-and-misoprostol-delayed. Based on FDA recall #D-0258-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0258-2015%22&limit=1).

Actavis Laboratories, FL, Inc. voluntarily recalled Diclofenac Sodium and Misoprostol Delayed-Release Tablets on Sept. 26, 2014, after the FDA identified split or broken tablets as a hazard. The Food and Drug Administration announced the Class II recall of 5,451 bottles distributed nationwide.

How to tell if you have it

  • Brand: Actavis
  • Product: Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75 mg/0.2 mg, 60-count bottle
  • NDC: 0591-0398-60
  • UPC: 3 05910 39860 6
  • Lot # 694320A
  • Expiry: 02/28/2015
  • Manufacturer: Watson Laboratories, Inc., Corona, CA

The hazard

The recall addresses the presence of split or broken tablets within the product. The FDA classified this as a Class II recall due to failed tablet specifications.

Context

GovInfoNow's records show Actavis Laboratories, FL, Inc. has five other recalls on file since April 24, 2014. Previous issues included incorrect expiration dates on Ramipril bottles in August 2016 and dissolution failures for Metformin ER in September 2015. Other recent recalls of similar products include Teva Metoprolol Succinate Tablets (Jan. 29, 2026) and Teva Recalls Metoprolol Succinate 50 mg Due to Dissolution Failure (Jan. 29, 2026).

How to tell if you have this one

Check your bottle for the brand Actavis (manufactured by Watson Laboratories), NDC 0591-0398-60, UPC 3 05910 39860 6. Specifically look for Lot # 694320A with an expiry date of 02/28/2015.

  • Brand
    Actavis
  • Product
    Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75 mg/0.2 mg, 60-count bottle, Rx only. Manufactured by
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Bottle

    Verify if your bottle matches NDC 0591-0398-60 and Lot # 694320A.

  2. Contact Your Pharmacist

    Since the remedy is not stated in the record, contact your pharmacy or healthcare provider for instructions on what to do next.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “U.S. Nationwide including Puerto Rico.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 9 months after the firm started it.

1. Firm started the recall: Sep 26, 201412. FDA classified it Class II: Nov 21, 201423. Published in FDA’s Enforcement Report: Dec 3, 201434. FDA terminated the recall: Jun 16, 2015420142015
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0258-2015 (September 26, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0258-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA